Stay updated on Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial page.

Latest updates to the Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial page
- Check7 days agoChange DetectedNo significant changes detected in the core study content; the title, conditions, interventions, outcomes, eligibility criteria, enrollment, and locations appear unchanged, and the page layout remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check14 days agoNo Change Detected
- Check36 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing content and status information have changed.”}{SummaryDifference3%

- Check43 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0 and new contact/identifier details added (email, phone, and an ID).SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Revision: v3.0.2; removed Revision: v3.0.1 and the Back to Top link.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check72 days agoChange DetectedThe web page has updated its facility name and location details, including specific drug information for Fruquintinib and HMPL-013, while removing previous location terms and references to related topics like lung cancer.SummaryDifference1%

Stay in the know with updates to Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial page.